Rosenblum Silverman Sutton’s Natera NTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$370K Sell
1,850
-50
-3% -$10.8K 0.1% 69
2025
Q4
$435K Sell
1,900
-100
-5% -$20.9K 0.1% 66
2025
Q3
$322K Hold
2,000
0.07% 69
2025
Q2
$338K Hold
2,000
0.08% 65
2025
Q1
$283K Hold
2,000
0.08% 69
2024
Q4
$317K Hold
2,000
0.08% 70
2024
Q3
$254K Hold
2,000
0.06% 73
2024
Q2
$217K Sell
2,000
-1,825
-48% -$185K 0.06% 75
2024
Q1
$350K Hold
3,825
0.1% 64
2023
Q4
$240K Buy
+3,825
New +$191K 0.08% 69
2023
Q2
Sell
-3,985
Closed -$221K 70
2023
Q1
$221K Buy
+3,985
New +$191K 0.08% 62
2022
Q4
Sell
-5,185
Closed -$227K 71
2022
Q3
$227K Sell
5,185
-27,415
-84% -$1.3M 0.08% 72
2022
Q2
$1.16M Buy
32,600
+1,210
+4% +$44.8K 0.38% 46
2022
Q1
$1.28M Sell
31,390
-5,705
-15% -$343K 0.33% 46
2021
Q4
$3.46M Sell
37,095
-14,545
-28% -$1.51M 0.78% 40
2021
Q3
$5.75M Buy
51,640
+11,825
+30% +$1.36M 1.32% 29
2021
Q2
$4.52M Buy
+39,815
New +$4.07M 1.02% 34

Other funds holding NTRA

Rosenblum Silverman Sutton's NTRA Position: Q1 2026 in Review

Rosenblum Silverman Sutton reduced its Natera (NTRA) stake by 2.6% in Q1 2026, selling an estimated $10.8K and leaving 1,850 shares worth $370K. The position accounts for 0.1% of the portfolio, ranked #69.

Rosenblum Silverman Sutton first reported a position in NTRA in Q2 2021 and has held it in 17 quarters since. The position peaked at $5.75M in Q3 2021. 761 funds tracked by Wall St. Rank hold NTRA as of Q1 2026.

  • Rosenblum Silverman Sutton held 1,850 shares of Natera worth $370K as of Q1 2026.
  • Rosenblum Silverman Sutton sold 50 Natera shares in Q1 2026, an estimated $10.8K.
  • Natera made up 0.1% of Rosenblum Silverman Sutton's portfolio in Q1 2026, its #69 holding.
  • Rosenblum Silverman Sutton first reported a position in Natera in Q2 2021 and has held it in 17 quarters since.
  • Rosenblum Silverman Sutton's Natera position peaked at $5.75M in Q3 2021.
  • 761 funds tracked by Wall St. Rank held Natera as of Q1 2026.

Based on Rosenblum Silverman Sutton's 13F filing for Q1 2026, filed 13 May 2026.